24 Stocks Moving in Tuesday's Pre-Market Session

This post was originally published on this site

© Provided by Benzinga

Gainers

Vertex Energy, Inc. (NASDAQ: VTNR) rose 43.5% to $11.21 in pre-market trading. Vertex Energy, shares jumped around 96% on Friday on continued momentum after the company announced it will acquire an Alabama refinery and related logistics assets for $75 million. Orbsat Corp (NASDAQ: OSAT) rose 37.1% to $5.76 in pre-market trading. The company recently reported pricing of upsized $14.4 million underwritten public offering and uplisting to Nasdaq. SCYNEXIS, Inc. (NASDAQ: SCYX) rose 27.5% to $12.21 in pre-market trading. The company, last month, reported a narrower quarterly loss. Cloudera, Inc. (NASDAQ: CLDR) shares rose 19% to $15.30 in pre-market trading. KKR & Co. and Clayton Dubilier & Rice LLC are nearing a deal to take Cloudera private, Bloomberg reported. Sundial Growers Inc. (NASDAQ: SNDL) rose 16.5% to $1.13 in pre-market trading after surging 15% on Friday. TD Holdings, Inc. (NASDAQ: GLG) shares rose 13.6% to $1.17 in pre-market trading. TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) rose 11.4% to $2.92 in pre-market trading. The company, last month, reported Q1 results. Washington Prime Group Inc. (NYSE: WPG) shares rose 10.4% to $2.45 in pre-market trading after climbing 12% on Friday. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) rose 10.1% to $2.39 in pre-market trading after gaining over 6% on Friday. 1847 Goedeker Inc. (NASDAQ: GOED) rose 9.9% to $2.00 in pre-market trading. The company recently priced its 91 million unit offering at $2.25 per unit. Cango Inc. (NYSE: CANG) rose 9.4% to $6.29 in pre-market trading after the company reported results for its first quarter. AMC Entertainment Holdings, Inc. (NYSE: AMC) rose 9.1% to $28.50 in pre-market trading. BlackBerry has overtaken GameStop and now emerged as the second-most mentioned stock just behind AMC Entertainment on Reddit’s r/WallStreetBets forum. Lizhi Inc. (NASDAQ: LIZI) rose 8.1% to $7.21 in pre-market trading. Lizhi recently announced its new LIZHI podcast app has been recommended by Apple’s app store as one of its featured apps. Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) rose 7.9% to $6.96 in pre-market trading. The company, last week, published a trial titled “A Trial to Learn More About a Possible Treatment For Participants With Acute Myeloid Leukemia” to ClinicalTrials.gov. BlackBerry Limited (NYSE: BB) rose 7.5% to $10.82 in pre-market trading. BlackBerry has overtaken GameStop and now emerged as the second-most mentioned stock just behind AMC Entertainment on Reddit’s r/WallStreetBets forum. Immutep Limited (NASDAQ: IMMP) rose 6.6% to $5.37 in pre-market trading after the company reported new collaboration with Merck KGaA, Darmstadt, Germany for LAG-3 therapy, Efti. Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) rose 6.4% to $1.66 in pre-market trading. B. Riley Securities, last week, initiated coverage on Eloxx Pharmaceuticals with a Buy rating and announced a price target of $5. Inpixon (NASDAQ: INPX) rose 5% to $1.11 in pre-market trading. Inpixon, last month, reported Q1 results. NIO Inc. (NYSE: NIO) rose 3.1% to $39.80 in pre-market trading. Chinese electric vehicle maker Nio said deliveries nearly doubled in May on a year-on-year basis but slipped sequentially amid an ongoing global semiconductor chip shortage.

Find out what’s going on in today’s market and bring any questions you have to Benzinga’s PreMarket Prep.

Load Error

Check out these big penny stock gainers and losers

Losers

SemiLEDs Corporation (NASDAQ: LEDS) shares fell 13.4% to $11.97 in pre-market trading after jumping 45% on Friday. eMagin Corporation (NASDAQ: EMAN) shares fell 10.3% to $3.65 in pre-market trading after jumping around 53% on Friday. Baudax Bio, Inc. (NASDAQ: BXRX) fell 7.4% to $0.8361 in pre-market trading after the company reported $11.9 million registered direct offering. Humanigen, Inc. (NASDAQ: HGEN) fell 6.6% to $18.90 in pre-market trading. Humanigen recently submitted an application to the FDA seeking Emergency Use Authorization (EUA) for lenzilumab to treat patients hospitalized with COVID-19. ENDRA Life Sciences Inc. (NASDAQ: NDRA) fell 6.1% to $1.99 in pre-market trading. The company, last month, reported Q1 results.

Continue Reading

Related Posts